164 related articles for article (PubMed ID: 15574463)
1. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder.
Fernet M; Gribaa M; Salih MA; Seidahmed MZ; Hall J; Koenig M
Hum Mol Genet; 2005 Jan; 14(2):307-18. PubMed ID: 15574463
[TBL] [Abstract][Full Text] [Related]
2. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder.
Delia D; Piane M; Buscemi G; Savio C; Palmeri S; Lulli P; Carlessi L; Fontanella E; Chessa L
Hum Mol Genet; 2004 Sep; 13(18):2155-63. PubMed ID: 15269180
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmic features of ataxia telangiectasia-like disorder.
Khan AO; Oystreck DT; Koenig M; Salih MA
J AAPOS; 2008 Apr; 12(2):186-9. PubMed ID: 18083591
[TBL] [Abstract][Full Text] [Related]
4. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
Taylor AM; Groom A; Byrd PJ
DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
[TBL] [Abstract][Full Text] [Related]
5. Independent roles for nibrin and Mre11-Rad50 in the activation and function of Atm.
Cerosaletti K; Concannon P
J Biol Chem; 2004 Sep; 279(37):38813-9. PubMed ID: 15234984
[TBL] [Abstract][Full Text] [Related]
6. Mre11 ATLD17/18 mutation retains Tel1/ATM activity but blocks DNA double-strand break repair.
Limbo O; Moiani D; Kertokalio A; Wyman C; Tainer JA; Russell P
Nucleic Acids Res; 2012 Dec; 40(22):11435-49. PubMed ID: 23080121
[TBL] [Abstract][Full Text] [Related]
7. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.
Shull ER; Lee Y; Nakane H; Stracker TH; Zhao J; Russell HR; Petrini JH; McKinnon PJ
Genes Dev; 2009 Jan; 23(2):171-80. PubMed ID: 19171781
[TBL] [Abstract][Full Text] [Related]
8. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.
Stewart GS; Maser RS; Stankovic T; Bressan DA; Kaplan MI; Jaspers NG; Raams A; Byrd PJ; Petrini JH; Taylor AM
Cell; 1999 Dec; 99(6):577-87. PubMed ID: 10612394
[TBL] [Abstract][Full Text] [Related]
9. Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly.
Matsumoto Y; Miyamoto T; Sakamoto H; Izumi H; Nakazawa Y; Ogi T; Tahara H; Oku S; Hiramoto A; Shiiki T; Fujisawa Y; Ohashi H; Sakemi Y; Matsuura S
DNA Repair (Amst); 2011 Mar; 10(3):314-21. PubMed ID: 21227757
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia.
Bohlega SA; Shinwari JM; Al Sharif LJ; Khalil DS; Alkhairallah TS; Al Tassan NA
BMC Med Genet; 2011 Feb; 12():27. PubMed ID: 21324166
[TBL] [Abstract][Full Text] [Related]
11. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex.
Lee JH; Paull TT
Science; 2004 Apr; 304(5667):93-6. PubMed ID: 15064416
[TBL] [Abstract][Full Text] [Related]
12. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex.
Stracker TH; Morales M; Couto SS; Hussein H; Petrini JH
Nature; 2007 May; 447(7141):218-21. PubMed ID: 17429352
[TBL] [Abstract][Full Text] [Related]
13. Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage.
Lee JH; Xu B; Lee CH; Ahn JY; Song MS; Lee H; Canman CE; Lee JS; Kastan MB; Lim DS
Mol Cancer Res; 2003 Jul; 1(9):674-81. PubMed ID: 12861053
[TBL] [Abstract][Full Text] [Related]
14. Assessment of carriers' frequency of a novel MRE11 mutation responsible for the rare ataxia telangiectasia-like disorder.
Alsbeih G; Al-Hadyan K; Al-Harbi N
Genet Test; 2008 Sep; 12(3):387-9. PubMed ID: 18652530
[TBL] [Abstract][Full Text] [Related]
15. Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template.
Williams RS; Williams JS; Tainer JA
Biochem Cell Biol; 2007 Aug; 85(4):509-20. PubMed ID: 17713585
[TBL] [Abstract][Full Text] [Related]
16. Three new cases of ataxia-telangiectasia-like disorder: No impairment of the ATM pathway, but S-phase checkpoint defect.
Fiévet A; Bellanger D; Valence S; Mobuchon L; Afenjar A; Giuliano F; Dubois d'Enghien C; Parfait B; Pedespan JM; Auger N; Rieunier G; Collet A; Burglen L; Stoppa-Lyonnet D; Stern MH
Hum Mutat; 2019 Oct; 40(10):1690-1699. PubMed ID: 31033087
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of ataxia telangiectasia and related diseases.
Ball LG; Xiao W
Acta Pharmacol Sin; 2005 Aug; 26(8):897-907. PubMed ID: 16038621
[TBL] [Abstract][Full Text] [Related]
18. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex.
Lee JH; Paull TT
Science; 2005 Apr; 308(5721):551-4. PubMed ID: 15790808
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Mre11/Rad50 by Nbs1: effects on nucleotide-dependent DNA binding and association with ataxia-telangiectasia-like disorder mutant complexes.
Lee JH; Ghirlando R; Bhaskara V; Hoffmeyer MR; Gu J; Paull TT
J Biol Chem; 2003 Nov; 278(46):45171-81. PubMed ID: 12966088
[TBL] [Abstract][Full Text] [Related]
20. ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance.
Ewald B; Sampath D; Plunkett W
Cancer Res; 2008 Oct; 68(19):7947-55. PubMed ID: 18829552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
